🧠 Addiction and anxiety: how they fuel each other (and how to treat both) ✨

Around half of Australians who present for alcohol or drug treatment also meet criteria for an anxiety disorder. The two conditions are tangled in ways that make either one harder to treat alone — and that historically led to people being bounced between AOD services and mental health services without ever being treated for the actual problem. This is what dual-diagnosis care looks like when it works, and how to access it in Australia.

Why anxiety and addiction so often co-occur

There is a chemistry reason and a psychology reason. The chemistry: alcohol, benzodiazepines, opioids, and cannabis all reduce activity in the central nervous system. For someone with an anxious brain, that is a powerful, immediate experience of relief. The psychology: anxiety is exhausting. People in anxious states will often do almost anything to interrupt them, and the substances that reliably interrupt them are also the substances most likely to produce dependence.

The trap is that the very substances that mute anxiety in the short term make it worse in the longer term. Tolerance climbs, doses rise, and the anxiety on the morning after a heavy drinking night — the racing heart, the catastrophising thoughts at 4am — is biologically more intense than baseline anxiety would have been. The brain has been trained to crash. Stop drinking and the rebound anxiety can take weeks to settle. People often interpret that rebound as evidence they "need" to drink, when in fact it is the cost of the previous month of drinking.

Why sequential treatment fails

Australian AOD services historically operated on a "get sober first, treat the anxiety later" model. Mental health services often operated the inverse: "get the anxiety stable first, treat the drinking later." For people with both, this meant being bounced between systems and treated for neither. The current consensus, codified in the National Comorbidity Guidelines, is that integrated treatment — both conditions addressed by the same team, at the same time — produces better outcomes for both. Most state public AOD services in Australia now operate on this model, at least in principle.

What integrated treatment looks like

Concretely, integrated treatment usually means:

• A single case manager or treatment plan that names both the AOD condition and the anxiety condition explicitly.
• Pharmacotherapy that takes both into account — for example, prescribing an SSRI early in detox rather than waiting six months, or being deliberate about not prescribing benzodiazepines for an anxiety disorder when the person has a substance use history.
• Psychological treatment that addresses both — typically CBT, with anxiety-specific modules (graded exposure, cognitive restructuring) and AOD-specific modules (relapse-prevention, urge surfing) interwoven rather than sequenced.
• Realistic timelines: most people will see meaningful anxiety reduction in the first three to six months of sustained sobriety, but the underlying anxiety disorder — if there is one — usually needs its own treatment beyond what stopping use alone delivers.

Diagnosis is hard, but it matters

A common diagnostic problem: someone presents with severe anxiety and heavy alcohol use. Is the anxiety driving the drinking, the drinking driving the anxiety, or both? The honest answer is that you often cannot tell until the person has been off alcohol for at least four to six weeks. Until then, "alcohol-induced anxiety disorder" and "primary anxiety disorder with alcohol use" can look identical clinically.

This is why the standard approach is to stop or stabilise use first, give the brain a few weeks to recalibrate, and then re-assess. Anxiety that resolves with sustained sobriety was probably substance-driven; anxiety that persists at meaningful levels four-plus weeks in is much more likely a primary disorder needing its own treatment. Either way, you have learned something useful.

The benzodiazepine question

Benzodiazepines (Valium, Xanax, Temazepam, Ativan) are very effective short-term treatments for acute anxiety and have a real role in supervised alcohol detox. They are also one of the most addictive medication classes commonly prescribed, and people with a substance use history are at sharply elevated risk of becoming dependent on them. Most AOD physicians will avoid prescribing benzodiazepines for ongoing anxiety in someone with a substance use history, except in very specific situations. SafeScript, Australia's real-time prescription monitoring system, has made this easier to manage clinically by flagging high-risk prescribing patterns.

The pharmacological alternatives — SSRIs and SNRIs (sertraline, escitalopram, venlafaxine), buspirone, propranolol for performance anxiety, pregabalin in selected cases — work better long-term and are not addictive in the same way. The downside is that they take four to eight weeks to take effect, which is a hard ask for a person in acute distress. Bridging that period without benzodiazepines is one of the harder pieces of dual-diagnosis prescribing.

Psychological approaches that actually help

The strongest evidence base for anxiety disorders is cognitive behavioural therapy (CBT), with specific protocols for panic, social anxiety, generalised anxiety, and OCD. For dual-diagnosis specifically, integrated CBT — sometimes called Seeking Safety, or specific protocols developed for AOD-anxiety comorbidity — has the strongest evidence.

Other useful approaches include Acceptance and Commitment Therapy (ACT), which has good evidence for both anxiety and substance use; mindfulness-based relapse prevention (MBRP), which directly trains tolerance of uncomfortable feelings without using; and exposure-based work for specific anxieties that the person has been avoiding by drinking.

What the timeline of recovery actually looks like

Realistic expectations help.

Weeks 1 to 4 of sobriety: anxiety often spikes before it improves. Sleep is broken. Cravings interweave with anxious rumination. This is biologically expected and almost always passes.

Weeks 4 to 12: baseline anxiety begins to settle. Sleep starts to repair. The "morning after" anxiety state — which many heavy drinkers had been living in for years without realising it — gradually fades. For some people, the underlying anxiety disorder becomes more visible during this phase, because there is no drinking on top of it any more.

Months 3 to 12: if anxiety persists at clinically meaningful levels, this is when primary-anxiety treatment in earnest begins. SSRIs, structured CBT, lifestyle work (sleep, exercise, caffeine reduction). Most people experience substantial improvement on this timeline, though ongoing treatment is often needed.

How to access integrated care in Australia

The simplest first step is a GP appointment with a Mental Health Care Plan and an explicit conversation about both substance use and anxiety. The GP can refer to a psychologist with dual-diagnosis experience, prescribe an SSRI, and connect you to a public AOD service if needed. State alcohol and drug lines can also navigate the local landscape — they know which public services have integrated dual-diagnosis teams. headspace (for under-25s) and Beyond Blue's NewAccess program both screen for substance use as part of their intake.

The thing not to do is settle for treatment that ignores half the picture. A psychologist who tells you to come back when you have stopped drinking, or an AOD service that does not ask about anxiety, is operating on an outdated model. You are entitled to integrated care, and in most parts of Australia in 2026, it is now actually available.